Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Persistence and recurrence after removal of idiopathic epiretinal membrane
Indexado
WoS WOS:001342167700002
Scopus SCOPUS_ID:85207347456
DOI 10.1038/S41433-024-03429-Y
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Objectives: To analyse the incidence of persistence and recurrence after the peeling of idiopathic epiretinal membrane (ERM) and to describe its clinical features. Methods: This retrospective study included 666 eyes (645 patients) that underwent macular surgery for ERM removal. Optical coherence tomographic (OCT) images taken within three months after surgery and at the following visits, clinical parameters and surgery related factors were analysed to investigate the incidence and associated factors of ERM persistence and recurrence. Postoperative ERM types were categorised depending on the size ( < 100 <mu>m, >= 100 mu m) and the location (foveal, parafoveal, outside the parafovea) Results: The mean follow-up time was 29.4 months. ERM persistence (examination within 3 months) was found in 29.6% of all eyes. Only 1.9% of the eyes presented foveal ERM persistence. Foveal recurrence, defined as reappearance or growth of persistent ERM covering the fovea, was found in 8.2%. In 84.4% of eyes with foveal ERM recurrence, postoperative persistence of ERM of varying severity were identified. None of the pre-operative or surgery related factors were found significantly associated with ERM recurrence. Persistent ERM within the parafovea was the most significant risk factor for foveal ERM recurrence. Conclusion: Recurrence of ERM is generally preceded by the persistence of ERM fragments found in the early postoperative period. Growth of ERM persistence from the parafoveal region was often the origin of foveal ERM recurrence. Insufficient peeling seems to be the most significant predisposing factor for foveal ERM recurrence.

Revista



Revista ISSN
Eye 0950-222X

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Ophthalmology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Reichel, Felix F. - Univ Hosp Tubingen - Alemania
Universitätsklinikum und Medizinische Fakultät Tübingen - Alemania
2 Labbe, Eduardo - Universidad del Desarrollo - Chile
3 Gelisken, Faik - Univ Hosp Tubingen - Alemania
Universitätsklinikum und Medizinische Fakultät Tübingen - Alemania
4 Seitz, Immanuel P. - Univ Hosp Tubingen - Alemania
Universitätsklinikum und Medizinische Fakultät Tübingen - Alemania
5 Hagazy, Sherif - Res Inst Ophthalmol - Egipto
Research Institute of Ophthalmology - Egipto
6 Dimopoulos, Spyridon - Univ Hosp Tubingen - Alemania
Universitätsklinikum und Medizinische Fakultät Tübingen - Alemania

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Projekt DEAL
Junior Clinician Scientist Programme of the Faculty of Medicine, Eberhard Karls University of Tuebingen, Germany
Medizinischen Fakultät, Eberhard Karls Universität Tübingen

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
F. Reichel received research funding from the Junior Clinician Scientist Programme of the Faculty of Medicine, Eberhard Karls University of Tuebingen, Germany. Open Access funding enabled and organized by Projekt DEAL.
F. Reichel received research funding from the Junior Clinician Scientist Programme of the Faculty of Medicine, Eberhard Karls University of Tuebingen, Germany. Open Access funding enabled and organized by Projekt DEAL.

Muestra la fuente de financiamiento declarada en la publicación.